Jeffrey A. Sparks, MD, MMSc

SAN DIEGO — In this video, Healio spoke with Jeffrey A. Sparks, MD, MMSc, results from a study conducted in India assessing the efficacy of treating rheumatoid arthritis with split-doses of methotrexate.

In this video, Jeffrey A. Sparks, MD, MMSc, provides a review of the ARIAA study presented at ACR Convergence 2021.

In this video, Jeffrey A. Sparks, MD, MMSc, discusses cluster-analysis data from ACR Convergence 2021, which investigated multimorbidity patterns among patients with rheumatoid arthritis.

Jeffrey A. Sparks, MD, MMSc, highlights a study from ACR Convergence 2021 that assessed biomarker predictors of rheumatoid arthritis-associated interstitial lung disease.

Jeffrey A. Sparks, MD, MMSc, speaks with Healio about a presentation from ACR Convergence 2021 that reported predictors of mortality based on both rheumatoid arthritis and lung characteristics.

In this video from ACR Convergence 2021, Jeffrey A. Sparks, MD, MMSc, associate physician at Brigham and Women's Hospital, discusses results from the TRAIL1 trial in which pirfenidone did not meet its primary endpoints.

In this video, Jeffrey A. Sparks, MD, MMSc, associate physician at Brigham and Women’s Hospital, talked about adapting practice to telehealth during the COVID-19 pandemic.

In this video, Jeffrey A. Sparks, MD, MMSc, associate physician at Brigham and Women's Hospital, offered take home messages from a study focused on rheumatoid arthritis-associated interstitial lung disease, or RA-ILD, presented at ACR 2020.

In this video, Jeffrey A. Sparks, MD, MMSc, associate physician at Brigham and Women's Hospital, explained the findings from his study that investigated the relationship between rheumatoid arthritis and pulmonary function.

In this video, Jeffrey A. Sparks, MD, MMSc, associate physician at Brigham and Women's Hospital, spoke with Healio about a cross-sectional study presented at ACR 2020 that delved into the “lipid paradox.”